Table 1 Demographics, baseline and clinical characteristics of COVID-19 pneumonia patients

Age (year)

 Median (IQR)

45 (34.5–55)

45 (35–53.5)

43 (34–57)

0.872

 Range

  19–49

106 (62.7)

50 (67.6)

56 (58.9)

0.392

  50–64

38 (22.5)

13 (17.6)

25 (26.3)

  ≥ 65

25 (14.8)

11 (14.9)

14 (14.7)

Sex

 Male

86 (50.9)

40 (54.1)

46 (48.4)

0.536

 Female

83 (49.1)

34 (45.9)

49 (51.6)

Temperature on admission (°C)

 Median (IQR)

36.8 (36.5–37.4)

37.0 (36.6–37.5)

36.8 (36.5–37.2)

0.076

 Range

  < 37.3

120 (71.0)

46 (62.1)

74 (77.9)

0.065

  37.3–38.0

37 (21.9)

21 (28.4)

16 (16.8)

  38.1–39.0

11 (6.5)

7 (9.5)

4 (4.2)

  > 39

1 (0.6)

0 (0)

1 (1.1)

Pulmonary auscultation on admission

 Crackles

9 (5.3)

5 (6.8)

4 (4.2)

0.507

 Stridor

0 (0)

0(0)

0 (0)

1.000

 Both

3 (1.8)

3 (4.1)

0 (0)

0.082

Complication

 Not less than one

53 (31.4)

19 (25.7)

34 (35.8)

0.183

  Recurrent respiratory infections

4 (2.4)

1 (1.4)

3 (3.2)

0.632

  Hypertension

19 (11.2)

6 (8.1)

13 (13.7)

0.329

  Diabetes

13 (7.7)

4 (5.4)

9 (9.5)

0.393

  Immunodeficiency

2 (1.2)

0 (0)

2 (2.1)

0.505

  Chronic obstructive pulmonary disease

3 (1.8)

1 (1.4)

2 (2.1)

1.000

  Cancer

2 (1.2)

1 (1.4)

1 (1.1)

1.000

  Cardiovascular and cerebrovascular diseases

10 (5.9)

2 (2.7)

8 (8.4)

0.189

Symptoms or signs

 Fever

123 (72.8)

58 (78.4)

65 (68.4)

0.167

 Cough

136 (80.5)

64 (86.5)

72 (75.8)

0.117

 Expectoration

71 (42.0)

28 (37.8)

43 (45.3)

0.350

 Hemoptysis

4 (2.4)

3 (4.1)

1 (1.1)

0.320

 Nasal congestion

3 (1.8)

1 (1.4)

2 (2.1)

1.000

 Headache

23 (13.6)

7 (9.5)

16 (16.8)

0.183

 Shortness of breath

37 (21.9)

20 (27.0)

17 (17.9)

0.190

 Muscle soreness

11 (6.5)

3 (4.1)

8 (8.4)

0.351

 Fatigue

73 (43.2)

32 (43.2)

41 (43.2)

1.000

 Gastrointestinal symptoms

53 (31.4)

22 (29.7)

31 (32.6)

0.740

Onset-visit interval (days)

 Median (IQR)

3 (1–6)

3 (1–6)

3 (1–6)

0.711